imrt / tomo / vmat / cyberknife / hdr brachytherapy · 2014. 4. 8. · hdr brachytherapy: rtog0321...

22
1 Jean Pouliot, PhD Professor and Vice Chair, Department of Radiation Oncology, Director of Physics Division UC-Berkeley - UCSF Graduate Program in Bioengineering IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy: Should Choices be Based on Dosimetric and Motion Considerations? Genitourinary Cancers Session, March 22nd, 2014 Monday, March 31, 14

Upload: others

Post on 10-Aug-2021

8 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

1

Jean Pouliot, PhDProfessor and Vice Chair,Department of Radiation Oncology,Director of Physics Division

UC-Berkeley - UCSF Graduate Program in Bioengineering

IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy:

Should Choices be Basedon Dosimetric and Motion Considerations?

Genitourinary Cancers Session, March 22nd, 2014

Monday, March 31, 14

Page 2: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

2

Disclosure

Industrial Research ContractsAccuray, Dosisoft, Philips, Siemens, Varian

GrantsUC-Proof of Concept 12-PC-247UCSF CTSI Catalyst Award 2014

Licensing AgreementNucletron/Elekta

Monday, March 31, 14

Page 3: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

3

Collaborators

Josephine Chen, PhDAdam Cunha, PhDMartina Descovich, PhDAaron Garcia, MSAlex Gottschalk, MDI-Chow Hsu, MDDilini Pinnaduwage, PhDMack Roach, MD

Monday, March 31, 14

Page 4: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

Educational Objectives

- Understand that each modality follows a paradigm

- Understand when motion management is required

IMRT - VMAT - TOMO - CK - HDR

Monday, March 31, 14

Page 5: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

Dose Distributions

Tomo

Ck

GammaK

Monday, March 31, 14

Page 6: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

Dose Distributions

Tomo CkGammaK

HDR

Monday, March 31, 14

Page 7: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

Dose Distributions

Monday, March 31, 14

Page 8: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

Dose Profiles

HDR Brachy

Monday, March 31, 14

Page 9: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

DOSIMETRIC COMPARISON

IMRT - VMAT - TOMO - CK - HDR

- 3 Patients (prostate volumes: 35, 36 & 40 cc)- Prostate, bladder, rectum, bladder, and urethra- All structures segmented by same physician- Specific clinical planning team for each modality was asked to plan as usual.

- Prostate only- No consideration of RBE

Monday, March 31, 14

Page 10: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

Average Dose Comparison

TOMO IMRT VMAT CK HDRBrachytherapy

Average Dose to Targetfor a Constant D95 103% 104% 105% 116% 147%

Falloff (V100/V50) 0.24 0.19 0.26 0.25 0.39

UrethraV120%(cc) 0 0 0 0 0

Monday, March 31, 14

Page 11: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

HDR Brachytherapy: RTOG0321

Percent Dose of Prescription Dose

Acute adverse event

Late adverse event... the dose-limiting structure for prostate HDR brachytherapy is in the target volume (urethra).

This is in contrast to external beam radiation therapy where the rectum is the dose-limiting structure.

Monday, March 31, 14

Page 12: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

Urethra-sparing dose distribution

Monday, March 31, 14

Page 13: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

CK Urethra Sparing

Objective: Mean urethra dose < Prescription

Monday, March 31, 14

Page 14: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

- 3 gold fiducial markers in prostate

- T1 and T2-weighted MRI (T1 for markers, T2 for urethra and prostate)

- Planning CT (1.5mm) and T2-weighted MRI are co-registered

- PTV = Prostate + 2mm expansion* (except posteriorly)

- OAR: Bladder, rectum, urethra, penis, testicles, bowel & femoral heads

UCSF Protocol for Prostate Robotic - SBRT

*  due  to  intrafraction  motion  

- Field sizes (Iris) ranging from largest aperture that fits the PTV contour to 12.5 mm-diameter opening are selected.

- Maximum of 200 MU per beam per fraction

- Four asymmetric shells are created around the PTV

Monday, March 31, 14

Page 15: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

Intra-fraction Prostate Motion

Study: 2438 alignment shifts/rotations during Y fractions for 13 consecutive prostate patients, with a 90 sec average time between image verifications.

- PTV Margin of 2mm- Time between images < 60 sec

Monday, March 31, 14

Page 16: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

Dose Planning Problematic: Difficult to predict level of OAR protection -> plan might not be optimal

Evidence-based dose constraintsfor prostate Ck-SBRT

Favorable Unfavorable

Objective: Use anatomy to determine possible level of sparing

Monday, March 31, 14

Page 17: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

- Dose limits depend on anatomy

- Expansion-Interception-Volume (EIV) EIV = intersection volume between the target and the organ at risk expanded by 5 mm.

Evidence-based dose constraintsfor prostate Ck-SBRT

Monday, March 31, 14

Page 18: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

- Clinical Use

Evidence-based dose constraintsfor prostate Ck-SBRT

nCi<1.25nCi≥1.25

-­‐  EIV  vs  V75

Descovich  et  al.,  “Improving  plan  quality  and  consistency  by  standardization  of  dose  constraintsin  prostate  cancer  patients  undergoing  stereotactic  body  radiation  therapy”,  JACMP  2014  (In  Press).

Monday, March 31, 14

Page 19: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

Tomotherapy

Fixed  Jaw TomoEdge

Supperior

Inferior

Monday, March 31, 14

Page 20: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

TOMO / IMRT / VMAT / CK / HDR

TOMO

IMRT

VMAT

CK

HDR

Target coverage and urethra protectioninsured by IGRT and dose uniformity

Urethra defined on MRI and intrafraction motion compensated via tracking

Urethra (defined via Foley) sparing via dose tunnel

⎫⎬⎭

Monday, March 31, 14

Page 21: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

TOMO / IMRT / VMAT / CK / HDR

TOMO

IMRT

VMAT

CK

HDR

Most uniform dose of linac IMRT techniques

Hypofractionated Tx, intra-fx tracking, ~long Tx time

One-fx Tx, long clinical experience, caution with catheter motion

Most clinical experience

Efficient way to deliver radiation, more than one arc needed.

Monday, March 31, 14

Page 22: IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy · 2014. 4. 8. · HDR Brachytherapy: RTOG0321 Percent Dose of Prescription Dose Acute adverse event... the dose-limiting structure

22

Thank You!

Questions?

Genitourinary Cancers Session, March 22nd, 2014

Monday, March 31, 14